Prospect: information for the patient
Captopril Alter 50 mg tablets EFG
Read this prospect carefully before starting to take this medicine, because it contains important information for you.
Captopril Alter is a medication that contains a substance called captopril, which belongs to a group of drugs known as angiotensin-converting enzyme inhibitors (ACE inhibitors). Captopril causes blood vessels to relax and reduces blood pressure.
Captopril Alter is indicated for the treatment of:
Do not take Captopril Alter
Consult your doctor or pharmacist if you are taking, have taken recently, or may need to take any of the following medications:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Captopril Alter
-An angiotensin II receptor antagonist (ARA) (also known as "sartanes" - e.g., valsartán, telmisartán, irbesartán), particularly if you have kidney problems related to diabetes.
-Aliskirén.
Your doctor may need to monitor your kidney function, blood pressure, and electrolyte levels (e.g., potassium) at regular intervals.
See also the information under the heading "Do not take Captopril Alter".
Be especially careful with Captopril Alter if you experience:
Excessive sweating and dehydration may lead to a sudden drop in blood pressure.
Inform your doctor that you are taking captopril if you are to undergo surgery or receive anesthetics.
As with other medications used to lower blood pressure, this medication may be less effective in black patients.
Consult your doctor, even if any of the above circumstances have occurred at any time.
Taking Captopril Alter with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Your doctor may need to adjust your dose and/or take other precautions:
If you are taking an angiotensin II receptor antagonist (ARA) or aliskirén (see also the information under the headings "Do not take Captopril Alter" and "Warnings and precautions").
Certain medications may interact with Captopril Alter. In these cases, you may need to change your dose or discontinue treatment with one of them.
It is essential to inform your doctor if you are taking any of the following medications:
Taking Captopril Alter with food and drinks
Captopril can be taken with or without food.
Inform your doctor if you are taking potassium supplements or consuming a diet rich in potassium.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Captopril Alter is not recommended for use in the first trimester of pregnancy and is contraindicated in the second and third trimesters of pregnancy.
If administered during the second and third trimesters of pregnancy, ACE inhibitors (the group to which captopril belongs) may cause fetal damage and death.
If pregnancy is detected, the administration of this medication should be discontinued as soon as possible.
Captopril Alter is not recommended for use during breastfeeding.
Driving and operating machinery
During treatment for high blood pressure, your ability to drive and operate machinery may be reduced, especially at the beginning of treatment, when the dose is changed, or when you consume alcohol. Do not drive or operate machinery if you experience any impairment of these functions.
Captopril Alter contains lactose
This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The dosage must be individualized, so your doctor will establish the appropriate dose for you and make any necessary adjustments.
Hypertension
The recommended initial dose for the treatment of high blood pressure is 25-50 mg per day, administered in two daily doses. Your doctor may gradually increase the dose up to 100-150 mg per day. Your doctor may recommend the concurrent administration of other medications that lower blood pressure.
Chronic heart failure
The recommended initial dose for chronic heart failure (to help the heart pump blood properly) is 6.25-12.5 mg two to three times a day. Your doctor may gradually increase the dose up to a maximum of 150 mg per day and will monitor you during the first weeks of treatment or when changing your dose.
Myocardial infarction
The usual dose after a myocardial infarction is a test dose of 6.25 mg. Your doctor may gradually increase the dose up to a maximum of 150 mg per day.
Renal problems
The recommended initial dose for the treatment of renal problems in patients with type 1 diabetes is 75-100 mg per day, administered in several daily doses.
The tablets should be swallowed with water and may be taken with or without food.
Remember to take your medication.
If you estimate that the effect of captopril is too strong or too weak, inform your doctor or pharmacist.
Your doctor will indicate the duration of treatment with captopril. Do not discontinue treatment prematurely, as only your doctor knows what is best for you.
Use in children
The recommended initial dose is 0.30 mg/kg of body weight. In children who require special precautions, the starting dose should be 0.15 mg/kg of body weight. The use of this medication in children and adolescents should be initiated under close medical supervision. Your doctor will indicate the number of daily doses.
Use in elderly patients
In elderly patients with renal function impairment and other organic alterations, lower doses than those recommended should be administered.
Patients with renal insufficiency
In patients with renal impairment, lower doses than those recommended should be administered.
If you take more Captopril Alter than you should
If you have taken more Captopril Alter than you should, consult your doctor or pharmacist immediately.
The symptoms of overdose include severe hypotension, shock, stupor, bradycardia (slowing of heart rate), electrolyte imbalances, and renal failure.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone 915 620 420.
If you forgot to take Captopril Alter
If you forgot to take the medication, take the dose as soon as you remember on the same day. If you miss a dose, take your normal dose the next day.Do not take a double dose to compensate for the missed doses.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The following side effects have been observed:
Frequent (may affect up to 1 in 10 people): loss of appetite, sleep disorders, altered taste, dizziness, headache, and tingling sensation, cough and difficulty breathing, nausea, vomiting, stomach irritation, abdominal pain, diarrhea, constipation, dry mouth, stomach ulcers, itching with or without skin rash (sometimes with fever, joint pain, and eosinophilia), skin rash, and hair loss.
Infrequent (may affect up to 1 in 100 people): tachycardia or arrhythmia (increased heart rate), chest pain, palpitations, hypotension, Raynaud's syndrome (crises of pallor followed by cyanosis and rubor, which occurs in the fingers of the hand), redness, pallor, swelling of the arms, legs, face, lips, tongue, and/or throat, chest pain, fatigue, discomfort.
Rare (may affect up to 1 in 1,000 people): feeling of sleepiness, mouth lesions, intestinal angioedema, renal function disorders including renal failure, renal insufficiency, and alterations in urine elimination.
Very rare (may affect up to 1 in 10,000 people): alterations in blood cell count, lymph node diseases, autoimmune diseases, changes in blood test results related to potassium and glucose levels, confusion, depression, stroke, blurred vision, cardiac arrest, cardiogenic shock, respiratory disorders, inflammation of the tongue, pancreatitis, liver damage, and yellow skin discoloration, hepatitis (inflammation of the liver) including necrosis, elevated liver enzymes and bilirubin, appearance of blisters accompanied by itching, Stevens-Johnson syndrome, light sensitivity, skin redness, skin peeling, muscle pain, joint pain, nephrotic syndrome, impotence, excessive breast volume in men, fever, alterations in blood cell count, and changes in blood test results.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Store in the original packaging.
Do not store at a temperature above 30°C.
Keep the packaging perfectly closed to protect it from moisture.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Captopril Alter Composition
Appearance of the product and content of the packaging
White, round, flat tablets with a groove on one of their faces.
The tablets are presented in blisters, in packs of 30 tablets.
Marketing authorization holder and manufacturer responsible
Laboratorios Alter, S.A.
C/ Mateo Inurria 30
28036 Madrid
Spain
Last review date of this leaflet: March 2019
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.